López Almaraz R, Hernández González M, Doménech Martínez E
Servicio de Neonatología, Hospital Universitario de Canarias, La Laguna, Tenerife.
An Esp Pediatr. 2001 Feb;54(2):160-4.
To analyze the incidence, etiology and management of infants born in 1977 with vertically transmitted bacteremia or suspected early neonatal sepsis.
The total number of newborn infants in this period was 2,365. We revised the clinical histories of the infants diagnosed with bacteremia and classified them into two groups: a) those with vertically transmitted bacteremias, according to the recommendations of the Castrillo Group, and b) those with suspected early onset neonatal sepsis in whom blood culture was positive and analytical data suggested bacterial infection but who showed no clinical symptoms of vertically transmitted sepsis. Birthweight, sex, gestational age, risk factors for neonatal infection, clinical signs and laboratory tests suggestive of bacterial infection and microbiological agents were analyzed. The clinical and analytical evolution of the treated and untreated newborn infants was studied.
The newborn infants were diagnosed with vertically transmitted bacteremia (an incidence of 4.2x1,000 live newborn infants) and 17 were diagnosed with suspected early onset neonatal sepsis (7.8x1,000 live newborns). All the infants had risk factors for neonatal sepsis. The most common of them was prolonged membrane rupture (>- 18 hours) due to which sepsis screening was carried out (hemogram, C-reactive protein at 12 and 36-48 hours of life, and blood culture). In both groups the most commonly isolated microorganism was group B streptococcus, which was found in 30% of vertically transmitted bacteremias and in 41.2% of suspected early onset neonatal sepsis. All the newborn infants with suspected sepsis and two with vertically transmitted bacteremia were treated without incident. The remaining eight infants with untreated vertically transmitted bacteremia were followed-up clinically ana analytically for one year, and remained asymptomatic.
The most common microorganism in vertically transmitted bacteremia and suspected early onset neonatal sepsis was group B streptococcus. None of the untreated infants developed late sepsis or meningitis. Our findings suggest that non-treatment of asymptomatic infants with vertically transmitted bacteremias is appropriate as long and close clinical surveillance is maintained.
分析1977年出生的患有垂直传播菌血症或疑似早发型新生儿败血症的婴儿的发病率、病因及治疗情况。
此期间新生儿总数为2365例。我们查阅了被诊断为菌血症婴儿的临床病史,并将他们分为两组:a)根据卡斯蒂略小组的建议,患有垂直传播菌血症的婴儿;b)血培养呈阳性且分析数据提示细菌感染,但无垂直传播败血症临床症状的疑似早发型新生儿败血症婴儿。分析了出生体重、性别、胎龄、新生儿感染危险因素、提示细菌感染的临床体征和实验室检查以及微生物病原体。研究了接受治疗和未接受治疗的新生儿的临床及分析演变情况。
新生儿被诊断为垂直传播菌血症(发病率为每1000例活产新生儿中有4.2例),17例被诊断为疑似早发型新生儿败血症(每1000例活产新生儿中有7.8例)。所有婴儿均有新生儿败血症的危险因素。其中最常见的是胎膜破裂时间延长(>18小时),因此进行了败血症筛查(血常规、出生后12小时及36 - 48小时的C反应蛋白以及血培养)。两组中最常分离出的微生物是B族链球菌,在30%的垂直传播菌血症病例和41.2%的疑似早发型新生儿败血症病例中发现该菌。所有疑似败血症的新生儿及2例垂直传播菌血症新生儿均接受治疗,未出现意外情况。其余8例未接受治疗的垂直传播菌血症婴儿接受了为期一年的临床及分析随访,仍无症状。
垂直传播菌血症和疑似早发型新生儿败血症中最常见的微生物是B族链球菌。未接受治疗的婴儿均未发生迟发性败血症或脑膜炎。我们的研究结果表明,只要保持长期密切的临床监测,对无症状的垂直传播菌血症婴儿不进行治疗是合适的。